These findings demonstrate that ALA treatment mitigates oxidative stress-induced ferroptosis in mice with diabetes induced by an HFD combined with low-dose STZ, activating the SLC7A11/GPX4 axis, a core antioxidant mechanism that counteracts lipid peroxidation. Here, GPX4 is linked to diabetes mellitus.